193 related articles for article (PubMed ID: 33495401)
1. Adaptor Protein ShcD/
Tilak M; Alural B; Wismer SE; Brasher MI; New LA; Sheridan SD; Perlis RH; Coppolino MG; Lalonde J; Jones N
Mol Cancer Res; 2021 May; 19(5):757-770. PubMed ID: 33495401
[TBL] [Abstract][Full Text] [Related]
2. The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor.
Wills MK; Tong J; Tremblay SL; Moran MF; Jones N
Mol Biol Cell; 2014 Mar; 25(6):739-52. PubMed ID: 24430869
[TBL] [Abstract][Full Text] [Related]
3. The ShcD phosphotyrosine adaptor subverts canonical EGF receptor trafficking.
Wills MKB; Lau HR; Jones N
J Cell Sci; 2017 Sep; 130(17):2808-2820. PubMed ID: 28724758
[TBL] [Abstract][Full Text] [Related]
4. Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype.
Liu D; Martin V; Fueyo J; Lee OH; Xu J; Cortes-Santiago N; Alonso MM; Aldape K; Colman H; Gomez-Manzano C
Oncotarget; 2010 Dec; 1(8):700-709. PubMed ID: 21321379
[TBL] [Abstract][Full Text] [Related]
5. Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
Cortes-Santiago N; Hossain MB; Gabrusiewicz K; Fan X; Gumin J; Marini FC; Alonso MM; Lang F; Yung WK; Fueyo J; Gomez-Manzano C
Oncotarget; 2016 Mar; 7(13):16146-57. PubMed ID: 26910374
[TBL] [Abstract][Full Text] [Related]
6. Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.
Jones N; Hardy WR; Friese MB; Jorgensen C; Smith MJ; Woody NM; Burden SJ; Pawson T
Mol Cell Biol; 2007 Jul; 27(13):4759-73. PubMed ID: 17452444
[TBL] [Abstract][Full Text] [Related]
7. Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.
Wills MK; Keyvani Chahi A; Lau HR; Tilak M; Guild BD; New LA; Lu P; Jacquet K; Meakin SO; Bisson N; Jones N
J Biol Chem; 2017 Apr; 292(14):5748-5759. PubMed ID: 28213521
[TBL] [Abstract][Full Text] [Related]
8. Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix.
Lee OH; Xu J; Fueyo J; Fuller GN; Aldape KD; Alonso MM; Piao Y; Liu TJ; Lang FF; Bekele BN; Gomez-Manzano C
Mol Cancer Res; 2006 Dec; 4(12):915-26. PubMed ID: 17189382
[TBL] [Abstract][Full Text] [Related]
9. Localization of phosphotyrosine adaptor protein ShcD/SHC4 in the adult rat central nervous system.
Robeson HN; Lau HR; New LA; Lalonde J; Armstrong JN; Jones N
BMC Neurosci; 2019 Dec; 20(1):57. PubMed ID: 31823725
[TBL] [Abstract][Full Text] [Related]
10. Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters.
Martin V; Xu J; Pabbisetty SK; Alonso MM; Liu D; Lee OH; Gumin J; Bhat KP; Colman H; Lang FF; Fueyo J; Gomez-Manzano C
Oncogene; 2009 Jun; 28(24):2358-63. PubMed ID: 19421150
[TBL] [Abstract][Full Text] [Related]
11. A nuclear export signal and oxidative stress regulate ShcD subcellular localisation: a potential role for ShcD in the nucleus.
Ahmed SB; Prigent SA
Cell Signal; 2014 Jan; 26(1):32-40. PubMed ID: 24036217
[TBL] [Abstract][Full Text] [Related]
12. Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.
Hu B; Thirtamara-Rajamani KK; Sim H; Viapiano MS
Mol Cancer Res; 2009 Nov; 7(11):1756-70. PubMed ID: 19887559
[TBL] [Abstract][Full Text] [Related]
13. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
[TBL] [Abstract][Full Text] [Related]
14. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
[TBL] [Abstract][Full Text] [Related]
15. Studying the ShcD and ERK interaction under acute oxidative stress conditions in melanoma cells.
Ahmed SBM; Amer S; Emad M; Rahmani M; Prigent SA
Int J Biochem Cell Biol; 2019 Jul; 112():123-133. PubMed ID: 31121283
[TBL] [Abstract][Full Text] [Related]
16. Reduction of Akt2 inhibits migration and invasion of glioma cells.
Zhang B; Gu F; She C; Guo H; Li W; Niu R; Fu L; Zhang N; Ma Y
Int J Cancer; 2009 Aug; 125(3):585-95. PubMed ID: 19330838
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SPARC expression inhibits cell migration and invasion in malignant gliomas.
Seno T; Harada H; Kohno S; Teraoka M; Inoue A; Ohnishi T
Int J Oncol; 2009 Mar; 34(3):707-15. PubMed ID: 19212676
[TBL] [Abstract][Full Text] [Related]
18. Precursor N-cadherin mediates glial cell line-derived neurotrophic factor-promoted human malignant glioma.
Xiong Y; Liu L; Zhu S; Zhang B; Qin Y; Yao R; Zhou H; Gao DS
Oncotarget; 2017 Apr; 8(15):24902-24914. PubMed ID: 28212546
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Tie2/Tek receptor in astrocytomas.
Zadeh G; Qian B; Okhowat A; Sabha N; Kontos CD; Guha A
Am J Pathol; 2004 Feb; 164(2):467-76. PubMed ID: 14742253
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
